Understanding Coronary Artery Disease
Coronary artery disease occurs when atherosclerotic plaque accumulates inside coronary arteries, restricting blood flow to the heart muscle. This narrowing develops gradually as cholesterol and inflammatory substances deposit in arterial walls. Some patients remain asymptomatic until a major event, while others experience progressive chest discomfort, shortness of breath, or fatigue during exertion.
The disease is multifactorial, driven by hypertension, smoking, diabetes, high cholesterol, sedentary lifestyle, and family history. Early identification through non-invasive testing allows physicians to intervene before acute myocardial infarction occurs, making risk stratification tools like the Duke score invaluable in contemporary cardiology.
Duke Treadmill Score Calculation
The Duke score integrates three variables obtained during a standardized Bruce protocol exercise test. Each component carries a different weight, reflecting its prognostic significance.
Duke Score = Exercise Duration − (5 × ST-segment Deviation) − (4 × Angina Index)
Exercise Duration— Minutes of exercise completed on the treadmill before stopping or reaching target heart rateST-segment Deviation— Maximum net ST-segment shift (depression or elevation) in millimeters, excluding aVR lead; normal is 0–0.5 mmAngina Index— Binary indicator: 0 = no chest pain during test, 1 = typical angina, 2 = angina as reason for stopping exercise
Risk Stratification and Interpretation
Duke scores fall into three distinct risk categories that correlate strongly with 4-year survival rates:
- Low-risk (≥5): 99% survival at 4 years. Further invasive testing usually unnecessary unless symptoms persist or ejection fraction is severely reduced.
- Intermediate-risk (−10 to +4): 95% survival at 4 years. Selective use of coronary angiography may be warranted based on symptom severity and other risk factors.
- High-risk (<−10): 79% survival at 4 years. Strongly suggests need for coronary angiography and possible revascularization.
Individual clinical context—including left ventricular function, extent of baseline ECG abnormalities, and symptomatic burden—should always inform final recommendations alongside the numerical score.
Key Considerations for Accurate Scoring
Proper test administration and interpretation require attention to several critical details.
- Protocol Adherence — The Duke score depends on exercise performed using the standard Bruce protocol with specific treadmill speed and grade increments every 3 minutes. Tests conducted with different protocols may produce non-comparable results and reduce score validity.
- ST-segment Measurement Precision — ST deviations must be measured at 60–80 milliseconds after the J point (the junction between QRS and ST segments). Even small measurement errors of 0.1–0.2 mm compound in the equation, potentially shifting patients between risk categories.
- Angina Classification Accuracy — Distinguish between exercise-induced angina and other chest discomfort. Dyspnea, musculoskeletal chest wall pain, or reflux-type sensations do not count as angina for scoring purposes and should be recorded as index 0.
- Test Termination Reason Matters — Scores are most valid when the patient achieves adequate stress (≥85% predicted maximum heart rate). Tests stopped early due to non-cardiac issues (fatigue, orthopedic limitation) may underestimate exercise capacity and yield artificially low scores.
Clinical Application and Limitations
The Duke treadmill score excels at risk stratification in symptomatic patients with intermediate pre-test probability of disease. It is less useful in asymptomatic screening or in populations with very high or very low baseline risk. The score also assumes normal baseline ECG and ejection fraction; patients with left ventricular hypertrophy, bundle branch blocks, or prior myocardial infarction may require alternative risk assessment tools.
Women and patients with atypical presentations may be underestimated by traditional scoring thresholds. Additionally, advances in imaging (coronary CT angiography, stress echocardiography) and biomarkers (high-sensitivity troponin) have expanded the diagnostic toolkit, meaning the Duke score is best viewed as one component of comprehensive cardiovascular risk assessment rather than a standalone decision rule.